stella
beta
ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar — Stella
Recruiting
Back to Chronic Spontaneous Urticaria (CSU) trials
Trial locations
(1 site)
France
CHU Montpellier, Montpellier
View full record on ClinicalTrials.gov